Patrick Daly

DocwireNews

The Atrial Fibrillation Better Care (ABC) pathway has been proposed for atrial fibrillation (AF) management. After reviewing patients with AF in the FANTASIIA registry, Mar&iacute;a Asunci&oacute;n Esteve-Pasto and collaborating researchers reported &ldquo;a lack of adherence to integrated care management of AF following the ABC pathway.&rdquo; They also noted that &ldquo;AF managed according to the ABC pathway was associated with a significant reduction in adverse outcomes during long follow-up, suggesting the benefit of a holistic and integrated approach to AF management.&rdquo;The findings were published in Frontiers in Cardiovascular Medicine.Esteve-Pasto and colleagues defined the ABC pathway as, &ldquo;A, Avoid stroke with anticoagulation; B, better symptom management; C, cardiovascular and comorbidity risk management.&rdquo;The study included 1,955 patients with AF who were receiving direct oral anticoagulants (DOAC) or vitamin K antagonists (VKA) between June 2013 and October 2014. To evaluate adherence to the ABC pathway, the authors defined &ldquo;A criterion&rdquo; as time in therapeutic range (TTR) of &ge;70% or correct DOAC dose; &ldquo;B criterion&rdquo; as European Hearty Rhythm Association (EHRA) Symptom Scale I&ndash;II; and &ldquo;C criterion&rdquo; as optimal management of risk and comorbidity factors. The authors additionally assessed the value of the three ABC pathway components for predicting major adverse events.Among the overall cohort, the researchers observed adherence to the A, B, and C criterion in 920 (47.1%), 1,791 (91.6%), and 682 (34.8%) patients, respectively. According to the authors, only 20.2% of patients had &ldquo;good control of AF according to the ABC pathway.&rdquo;Compared with non-adherence, A criterion adherence was independently associated with reduced cardiovascular mortality (hazard ratio [HR] = 0.67; 95% confidence interval [CI], 0.45&ndash;0.99; p = 0.048), and B criterion adherence was independently associated with:<ul>
<li>Reduced stroke (HR = 0.28; 95% CI, 0.14&ndash;0.59; p &lt;0.001)</li>
<li>All-cause mortality (HR = 0.49; 95% CI, 0.35&ndash;0.69; p &lt;0.001)</li>
<li>Cardiovascular mortality (HR = 0.39; 95% CI, 0.25&ndash;0.62); p &lt;0.001)</li>
<li>Major adverse cardiovascular events (HR = 0.41; 95% CI 0.28&ndash;0.62; p &lt;0.001)</li>
</ul>Finally, C criterion adherence was associated with significantly lower risk of myocardial infarction (HR = 0.31; 95% CI, 0.15&ndash;0.66; p &lt;0.001). Patients who were fully adherent to ABC had a significant reduction in major adverse cardiovascular events (HR = 0.64; 95% CI, 0.42&ndash;0.99; p = 0.042).In summary, Esteve-Pasto and colleagues wrote, &ldquo;Our study is one of the few based on a prospective cohort and provides more evidence for the use of ABC pathway as the integrated management of AF patients (both under VKA and DOAC), also highlighting the importance of the symptom management.&rdquo;

Bradley Marder, MD

Joel M. Topf, MD, FACP

Gout Studies: Transplant Waitlisting and Bone Erosion

NKF Spring Clinical Meetings 2025

Jayme Locke, MD, MPH

The Promise of Xenotransplantation

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Latest News

Use of the Atrial Fibrillation Better Care Pathway in Real-World Patients

Atrial Fibrillation

The Atrial Fibrillation Better Care (ABC) pathway has been proposed for atrial fibrillation (AF) management. After reviewing patients with AF in the FANTASIIA registry, María ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe